nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—CYP2C19—Sorafenib—liver cancer	0.154	0.284	CbGbCtD
Timolol—ABCB1—Sorafenib—liver cancer	0.124	0.229	CbGbCtD
Timolol—CYP2D6—Sorafenib—liver cancer	0.117	0.216	CbGbCtD
Timolol—ABCB1—Doxorubicin—liver cancer	0.0754	0.139	CbGbCtD
Timolol—CYP2D6—Doxorubicin—liver cancer	0.071	0.131	CbGbCtD
Timolol—Erythema—Sorafenib—liver cancer	0.00234	0.00577	CcSEcCtD
Timolol—Malnutrition—Sorafenib—liver cancer	0.00234	0.00577	CcSEcCtD
Timolol—Dysgeusia—Sorafenib—liver cancer	0.00229	0.00565	CcSEcCtD
Timolol—Stinging—Doxorubicin—liver cancer	0.00226	0.00557	CcSEcCtD
Timolol—Vasodilation—Epirubicin—liver cancer	0.00225	0.00555	CcSEcCtD
Timolol—Vasodilation procedure—Epirubicin—liver cancer	0.00225	0.00555	CcSEcCtD
Timolol—Arthropathy—Epirubicin—liver cancer	0.00217	0.00536	CcSEcCtD
Timolol—Lacrimation increased—Epirubicin—liver cancer	0.00215	0.00529	CcSEcCtD
Timolol—Angioedema—Sorafenib—liver cancer	0.00214	0.00527	CcSEcCtD
Timolol—Syncope—Sorafenib—liver cancer	0.0021	0.00517	CcSEcCtD
Timolol—Vasodilation—Doxorubicin—liver cancer	0.00208	0.00514	CcSEcCtD
Timolol—Vasodilation procedure—Doxorubicin—liver cancer	0.00208	0.00514	CcSEcCtD
Timolol—Loss of consciousness—Sorafenib—liver cancer	0.00206	0.00507	CcSEcCtD
Timolol—Cough—Sorafenib—liver cancer	0.00204	0.00503	CcSEcCtD
Timolol—Atrioventricular block—Epirubicin—liver cancer	0.00204	0.00503	CcSEcCtD
Timolol—Hypertension—Sorafenib—liver cancer	0.00202	0.00498	CcSEcCtD
Timolol—Arthropathy—Doxorubicin—liver cancer	0.00201	0.00496	CcSEcCtD
Timolol—Myalgia—Sorafenib—liver cancer	0.00199	0.00491	CcSEcCtD
Timolol—Arthralgia—Sorafenib—liver cancer	0.00199	0.00491	CcSEcCtD
Timolol—Lacrimation increased—Doxorubicin—liver cancer	0.00199	0.0049	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00198	0.00488	CcSEcCtD
Timolol—Abnormal dreams—Epirubicin—liver cancer	0.00195	0.00482	CcSEcCtD
Timolol—Dry mouth—Sorafenib—liver cancer	0.00195	0.0048	CcSEcCtD
Timolol—Anaphylactic shock—Sorafenib—liver cancer	0.00191	0.00471	CcSEcCtD
Timolol—Infection—Sorafenib—liver cancer	0.0019	0.00468	CcSEcCtD
Timolol—Atrioventricular block—Doxorubicin—liver cancer	0.00189	0.00465	CcSEcCtD
Timolol—Shock—Sorafenib—liver cancer	0.00188	0.00463	CcSEcCtD
Timolol—Nervous system disorder—Sorafenib—liver cancer	0.00187	0.00462	CcSEcCtD
Timolol—Blood urea increased—Epirubicin—liver cancer	0.00187	0.0046	CcSEcCtD
Timolol—Skin disorder—Sorafenib—liver cancer	0.00185	0.00457	CcSEcCtD
Timolol—Dry eye—Epirubicin—liver cancer	0.00183	0.0045	CcSEcCtD
Timolol—Anorexia—Sorafenib—liver cancer	0.00182	0.00449	CcSEcCtD
Timolol—Abnormal dreams—Doxorubicin—liver cancer	0.00181	0.00446	CcSEcCtD
Timolol—Pulmonary oedema—Epirubicin—liver cancer	0.00176	0.00434	CcSEcCtD
Timolol—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00174	0.00429	CcSEcCtD
Timolol—Blood urea increased—Doxorubicin—liver cancer	0.00173	0.00426	CcSEcCtD
Timolol—Abnormal vision—Epirubicin—liver cancer	0.00172	0.00425	CcSEcCtD
Timolol—Dyspnoea—Sorafenib—liver cancer	0.0017	0.0042	CcSEcCtD
Timolol—Dry eye—Doxorubicin—liver cancer	0.00169	0.00417	CcSEcCtD
Timolol—Dyspepsia—Sorafenib—liver cancer	0.00168	0.00414	CcSEcCtD
Timolol—Decreased appetite—Sorafenib—liver cancer	0.00166	0.00409	CcSEcCtD
Timolol—Gastrointestinal disorder—Sorafenib—liver cancer	0.00165	0.00406	CcSEcCtD
Timolol—Fatigue—Sorafenib—liver cancer	0.00165	0.00406	CcSEcCtD
Timolol—Pain—Sorafenib—liver cancer	0.00163	0.00403	CcSEcCtD
Timolol—Pulmonary oedema—Doxorubicin—liver cancer	0.00163	0.00402	CcSEcCtD
Timolol—Abnormal vision—Doxorubicin—liver cancer	0.0016	0.00394	CcSEcCtD
Timolol—Eye pain—Epirubicin—liver cancer	0.00159	0.00392	CcSEcCtD
Timolol—Cardiac failure congestive—Epirubicin—liver cancer	0.00158	0.0039	CcSEcCtD
Timolol—Gastrointestinal pain—Sorafenib—liver cancer	0.00156	0.00385	CcSEcCtD
Timolol—Dermatitis exfoliative—Epirubicin—liver cancer	0.00152	0.00375	CcSEcCtD
Timolol—Urticaria—Sorafenib—liver cancer	0.00152	0.00374	CcSEcCtD
Timolol—Abdominal pain—Sorafenib—liver cancer	0.00151	0.00372	CcSEcCtD
Timolol—Body temperature increased—Sorafenib—liver cancer	0.00151	0.00372	CcSEcCtD
Timolol—Eye pain—Doxorubicin—liver cancer	0.00147	0.00363	CcSEcCtD
Timolol—Cardiac failure—Epirubicin—liver cancer	0.00147	0.00363	CcSEcCtD
Timolol—Hypoglycaemia—Epirubicin—liver cancer	0.00147	0.00363	CcSEcCtD
Timolol—Cerebrovascular accident—Epirubicin—liver cancer	0.00146	0.00361	CcSEcCtD
Timolol—Cardiac failure congestive—Doxorubicin—liver cancer	0.00146	0.00361	CcSEcCtD
Timolol—Pain in extremity—Epirubicin—liver cancer	0.00144	0.00354	CcSEcCtD
Timolol—Diplopia—Epirubicin—liver cancer	0.00144	0.00354	CcSEcCtD
Timolol—Osteoarthritis—Epirubicin—liver cancer	0.00144	0.00354	CcSEcCtD
Timolol—Affect lability—Epirubicin—liver cancer	0.00141	0.00348	CcSEcCtD
Timolol—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00141	0.00347	CcSEcCtD
Timolol—Hypersensitivity—Sorafenib—liver cancer	0.00141	0.00347	CcSEcCtD
Timolol—Asthenia—Sorafenib—liver cancer	0.00137	0.00338	CcSEcCtD
Timolol—Cardiac arrest—Epirubicin—liver cancer	0.00136	0.00337	CcSEcCtD
Timolol—Hypoglycaemia—Doxorubicin—liver cancer	0.00136	0.00336	CcSEcCtD
Timolol—Cardiac failure—Doxorubicin—liver cancer	0.00136	0.00336	CcSEcCtD
Timolol—Mood swings—Epirubicin—liver cancer	0.00136	0.00335	CcSEcCtD
Timolol—Cerebrovascular accident—Doxorubicin—liver cancer	0.00136	0.00334	CcSEcCtD
Timolol—Pruritus—Sorafenib—liver cancer	0.00135	0.00333	CcSEcCtD
Timolol—Diplopia—Doxorubicin—liver cancer	0.00133	0.00328	CcSEcCtD
Timolol—Osteoarthritis—Doxorubicin—liver cancer	0.00133	0.00328	CcSEcCtD
Timolol—Pain in extremity—Doxorubicin—liver cancer	0.00133	0.00328	CcSEcCtD
Timolol—Liver function test abnormal—Epirubicin—liver cancer	0.00133	0.00327	CcSEcCtD
Timolol—Abdominal pain upper—Epirubicin—liver cancer	0.00131	0.00323	CcSEcCtD
Timolol—Affect lability—Doxorubicin—liver cancer	0.00131	0.00322	CcSEcCtD
Timolol—Diarrhoea—Sorafenib—liver cancer	0.00131	0.00322	CcSEcCtD
Timolol—Breast disorder—Epirubicin—liver cancer	0.0013	0.0032	CcSEcCtD
Timolol—Nasopharyngitis—Epirubicin—liver cancer	0.00128	0.00317	CcSEcCtD
Timolol—Cardiac arrest—Doxorubicin—liver cancer	0.00126	0.00311	CcSEcCtD
Timolol—Dizziness—Sorafenib—liver cancer	0.00126	0.00311	CcSEcCtD
Timolol—Mood swings—Doxorubicin—liver cancer	0.00126	0.0031	CcSEcCtD
Timolol—Asthma—Epirubicin—liver cancer	0.00124	0.00306	CcSEcCtD
Timolol—Liver function test abnormal—Doxorubicin—liver cancer	0.00123	0.00302	CcSEcCtD
Timolol—Vomiting—Sorafenib—liver cancer	0.00121	0.00299	CcSEcCtD
Timolol—Abdominal pain upper—Doxorubicin—liver cancer	0.00121	0.00299	CcSEcCtD
Timolol—Angina pectoris—Epirubicin—liver cancer	0.00121	0.00298	CcSEcCtD
Timolol—Rash—Sorafenib—liver cancer	0.0012	0.00297	CcSEcCtD
Timolol—Dermatitis—Sorafenib—liver cancer	0.0012	0.00297	CcSEcCtD
Timolol—Breast disorder—Doxorubicin—liver cancer	0.0012	0.00296	CcSEcCtD
Timolol—Headache—Sorafenib—liver cancer	0.0012	0.00295	CcSEcCtD
Timolol—Nasopharyngitis—Doxorubicin—liver cancer	0.00119	0.00293	CcSEcCtD
Timolol—Dysuria—Epirubicin—liver cancer	0.00116	0.00286	CcSEcCtD
Timolol—Upper respiratory tract infection—Epirubicin—liver cancer	0.00115	0.00284	CcSEcCtD
Timolol—Asthma—Doxorubicin—liver cancer	0.00115	0.00283	CcSEcCtD
Timolol—Nausea—Sorafenib—liver cancer	0.00113	0.0028	CcSEcCtD
Timolol—Weight decreased—Epirubicin—liver cancer	0.00112	0.00277	CcSEcCtD
Timolol—Hyperglycaemia—Epirubicin—liver cancer	0.00112	0.00276	CcSEcCtD
Timolol—Angina pectoris—Doxorubicin—liver cancer	0.00112	0.00276	CcSEcCtD
Timolol—Conjunctivitis—Epirubicin—liver cancer	0.00108	0.00265	CcSEcCtD
Timolol—Dysuria—Doxorubicin—liver cancer	0.00107	0.00265	CcSEcCtD
Timolol—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00107	0.00263	CcSEcCtD
Timolol—Sweating—Epirubicin—liver cancer	0.00106	0.00262	CcSEcCtD
Timolol—Epistaxis—Epirubicin—liver cancer	0.00104	0.00257	CcSEcCtD
Timolol—Weight decreased—Doxorubicin—liver cancer	0.00104	0.00256	CcSEcCtD
Timolol—Sinusitis—Epirubicin—liver cancer	0.00104	0.00256	CcSEcCtD
Timolol—Hyperglycaemia—Doxorubicin—liver cancer	0.00104	0.00255	CcSEcCtD
Timolol—Agranulocytosis—Epirubicin—liver cancer	0.00103	0.00255	CcSEcCtD
Timolol—Bradycardia—Epirubicin—liver cancer	0.00101	0.00249	CcSEcCtD
Timolol—Rhinitis—Epirubicin—liver cancer	0.000995	0.00246	CcSEcCtD
Timolol—Conjunctivitis—Doxorubicin—liver cancer	0.000995	0.00245	CcSEcCtD
Timolol—Sweating—Doxorubicin—liver cancer	0.000981	0.00242	CcSEcCtD
Timolol—Oedema peripheral—Epirubicin—liver cancer	0.000978	0.00241	CcSEcCtD
Timolol—Connective tissue disorder—Epirubicin—liver cancer	0.000976	0.00241	CcSEcCtD
Timolol—Epistaxis—Doxorubicin—liver cancer	0.000965	0.00238	CcSEcCtD
Timolol—Sinusitis—Doxorubicin—liver cancer	0.00096	0.00237	CcSEcCtD
Timolol—Visual impairment—Epirubicin—liver cancer	0.000957	0.00236	CcSEcCtD
Timolol—Agranulocytosis—Doxorubicin—liver cancer	0.000955	0.00236	CcSEcCtD
Timolol—Bradycardia—Doxorubicin—liver cancer	0.000935	0.00231	CcSEcCtD
Timolol—Eye disorder—Epirubicin—liver cancer	0.000928	0.00229	CcSEcCtD
Timolol—Tinnitus—Epirubicin—liver cancer	0.000926	0.00228	CcSEcCtD
Timolol—Cardiac disorder—Epirubicin—liver cancer	0.000922	0.00227	CcSEcCtD
Timolol—Rhinitis—Doxorubicin—liver cancer	0.000921	0.00227	CcSEcCtD
Timolol—Oedema peripheral—Doxorubicin—liver cancer	0.000905	0.00223	CcSEcCtD
Timolol—Connective tissue disorder—Doxorubicin—liver cancer	0.000903	0.00223	CcSEcCtD
Timolol—Angiopathy—Epirubicin—liver cancer	0.000901	0.00222	CcSEcCtD
Timolol—Immune system disorder—Epirubicin—liver cancer	0.000897	0.00221	CcSEcCtD
Timolol—Mediastinal disorder—Epirubicin—liver cancer	0.000895	0.00221	CcSEcCtD
Timolol—Arrhythmia—Epirubicin—liver cancer	0.000887	0.00219	CcSEcCtD
Timolol—Visual impairment—Doxorubicin—liver cancer	0.000885	0.00218	CcSEcCtD
Timolol—Alopecia—Epirubicin—liver cancer	0.000877	0.00216	CcSEcCtD
Timolol—Mental disorder—Epirubicin—liver cancer	0.00087	0.00215	CcSEcCtD
Timolol—Malnutrition—Epirubicin—liver cancer	0.000864	0.00213	CcSEcCtD
Timolol—Erythema—Epirubicin—liver cancer	0.000864	0.00213	CcSEcCtD
Timolol—Eye disorder—Doxorubicin—liver cancer	0.000859	0.00212	CcSEcCtD
Timolol—Tinnitus—Doxorubicin—liver cancer	0.000857	0.00211	CcSEcCtD
Timolol—Cardiac disorder—Doxorubicin—liver cancer	0.000853	0.0021	CcSEcCtD
Timolol—Tension—Epirubicin—liver cancer	0.000848	0.00209	CcSEcCtD
Timolol—Dysgeusia—Epirubicin—liver cancer	0.000846	0.00209	CcSEcCtD
Timolol—Nervousness—Epirubicin—liver cancer	0.00084	0.00207	CcSEcCtD
Timolol—Angiopathy—Doxorubicin—liver cancer	0.000834	0.00206	CcSEcCtD
Timolol—Immune system disorder—Doxorubicin—liver cancer	0.00083	0.00205	CcSEcCtD
Timolol—Mediastinal disorder—Doxorubicin—liver cancer	0.000828	0.00204	CcSEcCtD
Timolol—Arrhythmia—Doxorubicin—liver cancer	0.000821	0.00202	CcSEcCtD
Timolol—Vision blurred—Epirubicin—liver cancer	0.000815	0.00201	CcSEcCtD
Timolol—Alopecia—Doxorubicin—liver cancer	0.000812	0.002	CcSEcCtD
Timolol—Mental disorder—Doxorubicin—liver cancer	0.000805	0.00199	CcSEcCtD
Timolol—Erythema—Doxorubicin—liver cancer	0.0008	0.00197	CcSEcCtD
Timolol—Malnutrition—Doxorubicin—liver cancer	0.0008	0.00197	CcSEcCtD
Timolol—Tension—Doxorubicin—liver cancer	0.000785	0.00194	CcSEcCtD
Timolol—Dysgeusia—Doxorubicin—liver cancer	0.000783	0.00193	CcSEcCtD
Timolol—Nervousness—Doxorubicin—liver cancer	0.000777	0.00192	CcSEcCtD
Timolol—Vertigo—Epirubicin—liver cancer	0.000777	0.00192	CcSEcCtD
Timolol—Syncope—Epirubicin—liver cancer	0.000775	0.00191	CcSEcCtD
Timolol—Palpitations—Epirubicin—liver cancer	0.000764	0.00188	CcSEcCtD
Timolol—Loss of consciousness—Epirubicin—liver cancer	0.00076	0.00187	CcSEcCtD
Timolol—Cough—Epirubicin—liver cancer	0.000754	0.00186	CcSEcCtD
Timolol—Vision blurred—Doxorubicin—liver cancer	0.000754	0.00186	CcSEcCtD
Timolol—Hypertension—Epirubicin—liver cancer	0.000746	0.00184	CcSEcCtD
Timolol—Arthralgia—Epirubicin—liver cancer	0.000736	0.00182	CcSEcCtD
Timolol—Chest pain—Epirubicin—liver cancer	0.000736	0.00182	CcSEcCtD
Timolol—Myalgia—Epirubicin—liver cancer	0.000736	0.00182	CcSEcCtD
Timolol—Anxiety—Epirubicin—liver cancer	0.000733	0.00181	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000731	0.0018	CcSEcCtD
Timolol—Discomfort—Epirubicin—liver cancer	0.000727	0.00179	CcSEcCtD
Timolol—Dry mouth—Epirubicin—liver cancer	0.00072	0.00178	CcSEcCtD
Timolol—Vertigo—Doxorubicin—liver cancer	0.000719	0.00177	CcSEcCtD
Timolol—Syncope—Doxorubicin—liver cancer	0.000717	0.00177	CcSEcCtD
Timolol—Confusional state—Epirubicin—liver cancer	0.000711	0.00175	CcSEcCtD
Timolol—Palpitations—Doxorubicin—liver cancer	0.000707	0.00174	CcSEcCtD
Timolol—Oedema—Epirubicin—liver cancer	0.000705	0.00174	CcSEcCtD
Timolol—Anaphylactic shock—Epirubicin—liver cancer	0.000705	0.00174	CcSEcCtD
Timolol—Loss of consciousness—Doxorubicin—liver cancer	0.000703	0.00173	CcSEcCtD
Timolol—Infection—Epirubicin—liver cancer	0.000701	0.00173	CcSEcCtD
Timolol—Cough—Doxorubicin—liver cancer	0.000698	0.00172	CcSEcCtD
Timolol—Shock—Epirubicin—liver cancer	0.000694	0.00171	CcSEcCtD
Timolol—Nervous system disorder—Epirubicin—liver cancer	0.000692	0.00171	CcSEcCtD
Timolol—Hypertension—Doxorubicin—liver cancer	0.000691	0.0017	CcSEcCtD
Timolol—Skin disorder—Epirubicin—liver cancer	0.000685	0.00169	CcSEcCtD
Timolol—Hyperhidrosis—Epirubicin—liver cancer	0.000682	0.00168	CcSEcCtD
Timolol—Myalgia—Doxorubicin—liver cancer	0.000681	0.00168	CcSEcCtD
Timolol—Chest pain—Doxorubicin—liver cancer	0.000681	0.00168	CcSEcCtD
Timolol—Arthralgia—Doxorubicin—liver cancer	0.000681	0.00168	CcSEcCtD
Timolol—Anxiety—Doxorubicin—liver cancer	0.000679	0.00167	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000676	0.00167	CcSEcCtD
Timolol—Discomfort—Doxorubicin—liver cancer	0.000673	0.00166	CcSEcCtD
Timolol—Anorexia—Epirubicin—liver cancer	0.000672	0.00166	CcSEcCtD
Timolol—Dry mouth—Doxorubicin—liver cancer	0.000666	0.00164	CcSEcCtD
Timolol—Hypotension—Epirubicin—liver cancer	0.000659	0.00163	CcSEcCtD
Timolol—Confusional state—Doxorubicin—liver cancer	0.000658	0.00162	CcSEcCtD
Timolol—Oedema—Doxorubicin—liver cancer	0.000653	0.00161	CcSEcCtD
Timolol—Anaphylactic shock—Doxorubicin—liver cancer	0.000653	0.00161	CcSEcCtD
Timolol—Infection—Doxorubicin—liver cancer	0.000648	0.0016	CcSEcCtD
Timolol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000643	0.00159	CcSEcCtD
Timolol—Shock—Doxorubicin—liver cancer	0.000642	0.00158	CcSEcCtD
Timolol—Nervous system disorder—Doxorubicin—liver cancer	0.00064	0.00158	CcSEcCtD
Timolol—Insomnia—Epirubicin—liver cancer	0.000638	0.00157	CcSEcCtD
Timolol—Skin disorder—Doxorubicin—liver cancer	0.000634	0.00156	CcSEcCtD
Timolol—Paraesthesia—Epirubicin—liver cancer	0.000633	0.00156	CcSEcCtD
Timolol—Hyperhidrosis—Doxorubicin—liver cancer	0.000631	0.00156	CcSEcCtD
Timolol—Dyspnoea—Epirubicin—liver cancer	0.000629	0.00155	CcSEcCtD
Timolol—Somnolence—Epirubicin—liver cancer	0.000627	0.00155	CcSEcCtD
Timolol—Anorexia—Doxorubicin—liver cancer	0.000622	0.00153	CcSEcCtD
Timolol—Dyspepsia—Epirubicin—liver cancer	0.000621	0.00153	CcSEcCtD
Timolol—Decreased appetite—Epirubicin—liver cancer	0.000613	0.00151	CcSEcCtD
Timolol—Hypotension—Doxorubicin—liver cancer	0.00061	0.0015	CcSEcCtD
Timolol—Gastrointestinal disorder—Epirubicin—liver cancer	0.000609	0.0015	CcSEcCtD
Timolol—Fatigue—Epirubicin—liver cancer	0.000608	0.0015	CcSEcCtD
Timolol—Pain—Epirubicin—liver cancer	0.000603	0.00149	CcSEcCtD
Timolol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000595	0.00147	CcSEcCtD
Timolol—Insomnia—Doxorubicin—liver cancer	0.00059	0.00146	CcSEcCtD
Timolol—Paraesthesia—Doxorubicin—liver cancer	0.000586	0.00145	CcSEcCtD
Timolol—Dyspnoea—Doxorubicin—liver cancer	0.000582	0.00144	CcSEcCtD
Timolol—Feeling abnormal—Epirubicin—liver cancer	0.000581	0.00143	CcSEcCtD
Timolol—Somnolence—Doxorubicin—liver cancer	0.00058	0.00143	CcSEcCtD
Timolol—Gastrointestinal pain—Epirubicin—liver cancer	0.000577	0.00142	CcSEcCtD
Timolol—Dyspepsia—Doxorubicin—liver cancer	0.000575	0.00142	CcSEcCtD
Timolol—Decreased appetite—Doxorubicin—liver cancer	0.000567	0.0014	CcSEcCtD
Timolol—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000564	0.00139	CcSEcCtD
Timolol—Fatigue—Doxorubicin—liver cancer	0.000563	0.00139	CcSEcCtD
Timolol—Urticaria—Epirubicin—liver cancer	0.00056	0.00138	CcSEcCtD
Timolol—Pain—Doxorubicin—liver cancer	0.000558	0.00138	CcSEcCtD
Timolol—Abdominal pain—Epirubicin—liver cancer	0.000558	0.00138	CcSEcCtD
Timolol—Body temperature increased—Epirubicin—liver cancer	0.000558	0.00138	CcSEcCtD
Timolol—Feeling abnormal—Doxorubicin—liver cancer	0.000538	0.00133	CcSEcCtD
Timolol—Gastrointestinal pain—Doxorubicin—liver cancer	0.000534	0.00132	CcSEcCtD
Timolol—Hypersensitivity—Epirubicin—liver cancer	0.00052	0.00128	CcSEcCtD
Timolol—Urticaria—Doxorubicin—liver cancer	0.000519	0.00128	CcSEcCtD
Timolol—Abdominal pain—Doxorubicin—liver cancer	0.000516	0.00127	CcSEcCtD
Timolol—Body temperature increased—Doxorubicin—liver cancer	0.000516	0.00127	CcSEcCtD
Timolol—Asthenia—Epirubicin—liver cancer	0.000506	0.00125	CcSEcCtD
Timolol—Pruritus—Epirubicin—liver cancer	0.000499	0.00123	CcSEcCtD
Timolol—Diarrhoea—Epirubicin—liver cancer	0.000483	0.00119	CcSEcCtD
Timolol—Hypersensitivity—Doxorubicin—liver cancer	0.000481	0.00119	CcSEcCtD
Timolol—Asthenia—Doxorubicin—liver cancer	0.000468	0.00116	CcSEcCtD
Timolol—Dizziness—Epirubicin—liver cancer	0.000466	0.00115	CcSEcCtD
Timolol—Pruritus—Doxorubicin—liver cancer	0.000462	0.00114	CcSEcCtD
Timolol—Vomiting—Epirubicin—liver cancer	0.000449	0.00111	CcSEcCtD
Timolol—Diarrhoea—Doxorubicin—liver cancer	0.000447	0.0011	CcSEcCtD
Timolol—Rash—Epirubicin—liver cancer	0.000445	0.0011	CcSEcCtD
Timolol—Dermatitis—Epirubicin—liver cancer	0.000444	0.0011	CcSEcCtD
Timolol—Headache—Epirubicin—liver cancer	0.000442	0.00109	CcSEcCtD
Timolol—Dizziness—Doxorubicin—liver cancer	0.000432	0.00106	CcSEcCtD
Timolol—Nausea—Epirubicin—liver cancer	0.000419	0.00103	CcSEcCtD
Timolol—Vomiting—Doxorubicin—liver cancer	0.000415	0.00102	CcSEcCtD
Timolol—Rash—Doxorubicin—liver cancer	0.000412	0.00102	CcSEcCtD
Timolol—Dermatitis—Doxorubicin—liver cancer	0.000411	0.00101	CcSEcCtD
Timolol—Headache—Doxorubicin—liver cancer	0.000409	0.00101	CcSEcCtD
Timolol—Nausea—Doxorubicin—liver cancer	0.000388	0.000956	CcSEcCtD
Timolol—ADRB1—Signaling Pathways—PSMD10—liver cancer	3.44e-05	0.000648	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.4e-05	0.00064	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NR1H4—liver cancer	3.39e-05	0.000638	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—F2—liver cancer	3.38e-05	0.000636	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PSMA4—liver cancer	3.37e-05	0.000634	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PSMD10—liver cancer	3.37e-05	0.000634	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTA3—liver cancer	3.33e-05	0.000627	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTA4—liver cancer	3.31e-05	0.000623	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CG—liver cancer	3.3e-05	0.000622	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.26e-05	0.000614	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.25e-05	0.000612	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KDR—liver cancer	3.24e-05	0.00061	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.24e-05	0.000609	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CG—liver cancer	3.23e-05	0.000608	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTA4—liver cancer	3.23e-05	0.000608	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTA2—liver cancer	3.23e-05	0.000607	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MAPK14—liver cancer	3.22e-05	0.000606	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ESR1—liver cancer	3.16e-05	0.000595	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTA2—liver cancer	3.15e-05	0.000593	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—F2—liver cancer	3.13e-05	0.00059	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—F2—liver cancer	3.12e-05	0.000587	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTA1—liver cancer	3.11e-05	0.000586	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NAT2—liver cancer	3.08e-05	0.00058	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—F2—liver cancer	3.07e-05	0.000577	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTA4—liver cancer	3.05e-05	0.000573	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTA1—liver cancer	3.04e-05	0.000572	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.04e-05	0.000572	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.01e-05	0.000567	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NAT2—liver cancer	3e-05	0.000566	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CG—liver cancer	3e-05	0.000565	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—APC—liver cancer	2.99e-05	0.000562	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CG—liver cancer	2.99e-05	0.000562	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTA2—liver cancer	2.97e-05	0.000559	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.96e-05	0.000557	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALDOB—liver cancer	2.95e-05	0.000556	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CG—liver cancer	2.93e-05	0.000553	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CD—liver cancer	2.9e-05	0.000547	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALDOB—liver cancer	2.88e-05	0.000542	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTA1—liver cancer	2.86e-05	0.000539	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CD—liver cancer	2.84e-05	0.000535	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NAT2—liver cancer	2.83e-05	0.000533	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CRABP1—liver cancer	2.81e-05	0.00053	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—BRAF—liver cancer	2.81e-05	0.000528	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.77e-05	0.000521	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CRABP1—liver cancer	2.75e-05	0.000517	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.75e-05	0.000517	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALDOB—liver cancer	2.71e-05	0.000511	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.68e-05	0.000504	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PRKCE—liver cancer	2.67e-05	0.000502	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CD—liver cancer	2.64e-05	0.000497	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CD—liver cancer	2.62e-05	0.000494	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PRKCE—liver cancer	2.61e-05	0.000491	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—PIK3CA—liver cancer	2.6e-05	0.000489	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SERPINE1—liver cancer	2.6e-05	0.000489	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CRABP1—liver cancer	2.59e-05	0.000488	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CD—liver cancer	2.58e-05	0.000486	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—KRAS—liver cancer	2.57e-05	0.000484	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.53e-05	0.000477	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CB—liver cancer	2.53e-05	0.000477	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF2—liver cancer	2.53e-05	0.000476	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CB—liver cancer	2.48e-05	0.000466	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF2—liver cancer	2.47e-05	0.000465	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HPGDS—liver cancer	2.46e-05	0.000463	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.45e-05	0.000461	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HPGDS—liver cancer	2.4e-05	0.000452	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PIK3CA—liver cancer	2.36e-05	0.000445	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CSF2—liver cancer	2.36e-05	0.000444	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—RAF1—liver cancer	2.35e-05	0.000443	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RAF1—liver cancer	2.34e-05	0.000441	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—H2AFX—liver cancer	2.33e-05	0.000438	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—IL2—liver cancer	2.32e-05	0.000438	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CSF2—liver cancer	2.31e-05	0.000435	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—RAF1—liver cancer	2.3e-05	0.000434	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CB—liver cancer	2.3e-05	0.000433	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MTOR—liver cancer	2.29e-05	0.000431	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CB—liver cancer	2.29e-05	0.000431	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—H2AFX—liver cancer	2.27e-05	0.000428	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—IL2—liver cancer	2.27e-05	0.000428	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HPGDS—liver cancer	2.26e-05	0.000426	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.26e-05	0.000426	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CB—liver cancer	2.25e-05	0.000423	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.23e-05	0.00042	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.2e-05	0.000414	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PSMA4—liver cancer	2.19e-05	0.000413	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PSMD10—liver cancer	2.19e-05	0.000413	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—HRAS—liver cancer	2.18e-05	0.000411	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1B—liver cancer	2.15e-05	0.000404	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PSMD10—liver cancer	2.14e-05	0.000403	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PSMA4—liver cancer	2.14e-05	0.000403	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GOT2—liver cancer	2.13e-05	0.000402	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT1—liver cancer	2.12e-05	0.0004	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL2—liver cancer	2.11e-05	0.000397	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CASP3—liver cancer	2.1e-05	0.000396	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TERT—liver cancer	2.1e-05	0.000396	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL2—liver cancer	2.1e-05	0.000396	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—liver cancer	2.09e-05	0.000394	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GOT2—liver cancer	2.08e-05	0.000392	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL2—liver cancer	2.06e-05	0.000389	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—liver cancer	2.06e-05	0.000387	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCND1—liver cancer	2.05e-05	0.000386	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—JUN—liver cancer	2.04e-05	0.000385	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.04e-05	0.000384	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CTNNB1—liver cancer	2.03e-05	0.000382	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PSMA4—liver cancer	2.02e-05	0.00038	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PSMD10—liver cancer	2.02e-05	0.00038	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP2E1—liver cancer	2.01e-05	0.000378	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—liver cancer	1.99e-05	0.000374	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1A—liver cancer	1.98e-05	0.000373	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GOT2—liver cancer	1.96e-05	0.000369	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2E1—liver cancer	1.96e-05	0.000369	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.94e-05	0.000366	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MAPK8—liver cancer	1.93e-05	0.000364	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—liver cancer	1.93e-05	0.000363	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KDR—liver cancer	1.92e-05	0.000362	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK14—liver cancer	1.91e-05	0.00036	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KDR—liver cancer	1.88e-05	0.000354	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYCS—liver cancer	1.88e-05	0.000353	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ESR1—liver cancer	1.87e-05	0.000353	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK14—liver cancer	1.87e-05	0.000352	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—F2—liver cancer	1.85e-05	0.000349	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.85e-05	0.000348	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2E1—liver cancer	1.84e-05	0.000347	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GOT1—liver cancer	1.84e-05	0.000347	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GGT1—liver cancer	1.84e-05	0.000347	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ESR1—liver cancer	1.83e-05	0.000345	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYCS—liver cancer	1.83e-05	0.000345	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—F2—liver cancer	1.81e-05	0.000341	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GGT1—liver cancer	1.8e-05	0.000338	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GOT1—liver cancer	1.8e-05	0.000338	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—liver cancer	1.79e-05	0.000336	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CG—liver cancer	1.77e-05	0.000334	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APC—liver cancer	1.77e-05	0.000334	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—STAT3—liver cancer	1.77e-05	0.000333	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CG—liver cancer	1.73e-05	0.000326	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APC—liver cancer	1.73e-05	0.000326	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYCS—liver cancer	1.73e-05	0.000325	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GOT1—liver cancer	1.69e-05	0.000319	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GGT1—liver cancer	1.69e-05	0.000319	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BRAF—liver cancer	1.67e-05	0.000314	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTP1—liver cancer	1.65e-05	0.000311	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—liver cancer	1.64e-05	0.000309	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TGFB1—liver cancer	1.64e-05	0.000309	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HMOX1—liver cancer	1.63e-05	0.000307	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BRAF—liver cancer	1.63e-05	0.000307	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTP1—liver cancer	1.61e-05	0.000304	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HMOX1—liver cancer	1.59e-05	0.0003	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CD—liver cancer	1.56e-05	0.000293	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CA—liver cancer	1.54e-05	0.000291	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SERPINE1—liver cancer	1.54e-05	0.00029	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—KRAS—liver cancer	1.53e-05	0.000287	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CD—liver cancer	1.52e-05	0.000287	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTP1—liver cancer	1.52e-05	0.000286	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTM1—liver cancer	1.52e-05	0.000286	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KRAS—liver cancer	1.52e-05	0.000286	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CA—liver cancer	1.51e-05	0.000284	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SERPINE1—liver cancer	1.51e-05	0.000284	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HMOX1—liver cancer	1.5e-05	0.000283	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—KRAS—liver cancer	1.49e-05	0.000281	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTM1—liver cancer	1.48e-05	0.000279	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1A1—liver cancer	1.44e-05	0.000271	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1A1—liver cancer	1.41e-05	0.000265	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CA—liver cancer	1.4e-05	0.000264	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTM1—liver cancer	1.4e-05	0.000263	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CA—liver cancer	1.39e-05	0.000263	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RAF1—liver cancer	1.39e-05	0.000262	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CA—liver cancer	1.37e-05	0.000258	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RAF1—liver cancer	1.36e-05	0.000256	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CB—liver cancer	1.36e-05	0.000256	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MTOR—liver cancer	1.36e-05	0.000256	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—liver cancer	1.35e-05	0.000254	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MTHFR—liver cancer	1.34e-05	0.000253	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MTOR—liver cancer	1.33e-05	0.00025	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CB—liver cancer	1.33e-05	0.00025	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1A1—liver cancer	1.33e-05	0.00025	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARA—liver cancer	1.32e-05	0.000248	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MTHFR—liver cancer	1.31e-05	0.000247	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HRAS—liver cancer	1.3e-05	0.000244	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HRAS—liver cancer	1.29e-05	0.000243	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARA—liver cancer	1.29e-05	0.000242	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1B—liver cancer	1.27e-05	0.00024	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HRAS—liver cancer	1.27e-05	0.000239	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—liver cancer	1.26e-05	0.000237	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—liver cancer	1.25e-05	0.000235	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL2—liver cancer	1.25e-05	0.000235	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1B—liver cancer	1.25e-05	0.000235	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—liver cancer	1.24e-05	0.000234	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTHFR—liver cancer	1.24e-05	0.000233	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—liver cancer	1.23e-05	0.000233	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—liver cancer	1.23e-05	0.000232	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—liver cancer	1.22e-05	0.00023	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL2—liver cancer	1.22e-05	0.00023	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCND1—liver cancer	1.22e-05	0.000229	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—liver cancer	1.21e-05	0.000229	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JUN—liver cancer	1.21e-05	0.000228	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARA—liver cancer	1.21e-05	0.000228	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CTNNB1—liver cancer	1.2e-05	0.000227	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCND1—liver cancer	1.19e-05	0.000224	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JUN—liver cancer	1.19e-05	0.000223	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.18e-05	0.000223	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—liver cancer	1.18e-05	0.000222	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CTNNB1—liver cancer	1.18e-05	0.000222	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1A—liver cancer	1.18e-05	0.000221	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—liver cancer	1.15e-05	0.000217	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1A—liver cancer	1.15e-05	0.000217	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK8—liver cancer	1.15e-05	0.000216	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—liver cancer	1.14e-05	0.000216	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—liver cancer	1.14e-05	0.000215	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CG—liver cancer	1.13e-05	0.000213	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK8—liver cancer	1.12e-05	0.000211	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—liver cancer	1.12e-05	0.000211	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CG—liver cancer	1.1e-05	0.000207	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARG—liver cancer	1.09e-05	0.000205	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARG—liver cancer	1.06e-05	0.0002	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—liver cancer	1.06e-05	0.0002	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STAT3—liver cancer	1.05e-05	0.000198	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CG—liver cancer	1.04e-05	0.000195	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—liver cancer	1.04e-05	0.000195	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STAT3—liver cancer	1.03e-05	0.000193	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARG—liver cancer	1e-05	0.000189	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CD—liver cancer	9.92e-06	0.000187	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALB—liver cancer	9.8e-06	0.000184	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—liver cancer	9.75e-06	0.000184	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TGFB1—liver cancer	9.73e-06	0.000183	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CD—liver cancer	9.68e-06	0.000182	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALB—liver cancer	9.56e-06	0.00018	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—liver cancer	9.54e-06	0.00018	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFB1—liver cancer	9.52e-06	0.000179	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CD—liver cancer	9.13e-06	0.000172	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KRAS—liver cancer	9.01e-06	0.00017	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALB—liver cancer	9.01e-06	0.00017	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KRAS—liver cancer	8.81e-06	0.000166	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CB—liver cancer	8.65e-06	0.000163	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CB—liver cancer	8.44e-06	0.000159	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CA—liver cancer	8.28e-06	0.000156	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CA—liver cancer	8.1e-06	0.000152	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—liver cancer	8.01e-06	0.000151	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CB—liver cancer	7.95e-06	0.00015	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—liver cancer	7.83e-06	0.000147	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HRAS—liver cancer	7.66e-06	0.000144	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HRAS—liver cancer	7.49e-06	0.000141	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—liver cancer	7.33e-06	0.000138	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—liver cancer	7.17e-06	0.000135	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—liver cancer	6.76e-06	0.000127	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—liver cancer	6.61e-06	0.000125	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CA—liver cancer	5.27e-06	9.93e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CA—liver cancer	5.15e-06	9.69e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CA—liver cancer	4.85e-06	9.13e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—liver cancer	4.31e-06	8.11e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—liver cancer	4.2e-06	7.92e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—liver cancer	3.96e-06	7.46e-05	CbGpPWpGaD
